## Abstract The aim of newborn screening is to identify presymptomatic healthy infants that will develop significant metabolic or endocrine derangements if left undiagnosed and untreated. The goal of ultimately reducing or eliminating irreversible sequelae is reached by maximizing test sensitivity
Structures for clinical follow-up: Newborn screening
β Scribed by R. Rodney Howell; Gilian Engelson
- Book ID
- 106374269
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 228 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0141-8955
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The inheritance of sickle-cell anemia upon the background of the major β€-globin gene cluster haplotypes has been associated with differing risks for major organ failure, and more recently with response to hydroxyurea treatment. Early identification of β€-globin haplotypes in individuals with sickle-c
Sweat testing remains the "gold standard" for the diagnosis of cystic fibrosis (CF) and is a critical component of newborn screening programs. We retrospectively reviewed sweat test results reported to a neonatal screening program for CF with respect to completeness of reported results and the value